Cerebral microbleeds in predialysis patients with chronic kidney disease | Zendy

Hisato Shima | Zendy; E. Ishimura | Zendy; Toshihide Naganuma | Zendy; T. Yamazaki | Zendy; I. Kobayashi | Zendy; K. Shidara | Zendy; Katsuhito Mori | Zendy; Yoshiaki Takemoto | Zendy; Tetsuo Shoji | Zendy; Minoru Inaba | Zendy; M. Okamura | Zendy; Tatsuya Nakatani | Zendy; Yoshiki Nishizawà | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cerebral microbleeds in predialysis patients with chronic kidney disease

Author(s) -

Hisato Shima,

E. Ishimura,

Toshihide Naganuma,

T. Yamazaki,

I. Kobayashi,

K. Shidara,

Katsuhito Mori,

Yoshiaki Takemoto,

Tetsuo Shoji,

Minoru Inaba,

M. Okamura,

Tatsuya Nakatani,

Yoshiki Nishizawà

Publication year - 2009

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfp694

Subject(s) - medicine , kidney disease , renal function , dyslipidemia , risk factor , diabetes mellitus , blood pressure , magnetic resonance imaging , stroke (engine) , cardiology , population , disease , radiology , endocrinology , mechanical engineering , environmental health , engineering

Gradient-echo T2*-weighted magnetic resonance imaging (T2*-weighted MRI) is highly sensitive for detecting cerebral microbleeds (CMBs). CMBs have been reported to be a risk factor for future cerebrovascular events and a marker of cerebral small vessel disease in the general population. Chronic kidney disease (CKD) is an independent risk factor for cardiovascular disease. The relationship between CKD and CMBs, which has not been clarified to date, is examined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research